Latest news with #CollectiveProject
National Post
27-05-2025
- Business
- National Post
Organigram Global Announces CEO Succession Plan
Article content Article content TORONTO — Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), ('the Company' or 'Organigram'), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the 'Board') to advance Organigram's strategic objectives, including international expansion, and to ensure an effective transition. Article content Since joining Organigram as CEO in September 2021, Ms. Goldenberg successfully led the organization's growth and transformation from a cannabis company with $80M in net revenue to becoming the market share leader in Canada with over $250M in net revenue. Under her leadership, the Company completed an expansion of its facility in Moncton, New Brunswick, doubling cultivation capacity, as well as three strategic acquisitions that led to the Company's #1 share positions in vapes, hash and pre-rolls in Canada. In addition, Ms. Goldenberg oversaw Organigram's international expansion with export sales into Germany, UK and Australia. The latest acquisition of Collective Project, announced on April 1, 2025, signaled the first revenue recognized by Organigram from the U.S. market. Article content This announcement follows the Company's second quarter fiscal year 2025 results, which were issued on May 12, 2025, and highlight the progress that has been made in enhancing Organigram's financial performance. This includes realizing a 74% increase in net revenue year-over-year and delivering improvement across key financial metrics. Article content 'After five incredible years in the cannabis industry, serving as CEO of Supreme Cannabis Company and Organigram Global, I have decided it is time to move on to my next chapter,' said Ms. Goldenberg. 'Reflecting on my journey, I am extremely proud of what has been accomplished in this nascent industry. The challenges we faced and the successes we achieved underscore the immense potential that still lies ahead for the cannabis industry.' Article content 'On behalf of the Board, I express our gratitude to Beena for her exceptional leadership and commitment to Organigram. Beena has been instrumental in positioning Organigram as a market leader in Canada and poised for global expansion,' said Peter Amirault, Chairman of the Board, Organigram. 'She has created an excellent base for both domestic and international growth for Organigram. And therefore, the Company is well positioned to take advantage of this significant opportunity. The Board remains confident in the Company's strategic direction as well as its leadership team, and we are committed to appointing a new CEO who will continue to drive our vision forward, ensuring that the Company remains at the forefront of cannabis innovation and growth.' Article content The Board is in the process of initiating a comprehensive CEO selection process focused on identifying a candidate with the right mix of skills and experience to lead the Company in its next chapter of growth. Article content 'It has been an honour to lead Organigram Global through this critical chapter in our evolution, and I am grateful to have had the privilege of working with so many talented and passionate people who have played a significant role in our collective growth and achievements,' said Ms. Goldenberg. 'Over the next four months I will remain focused on driving Organigram growth and profitability while supporting the smooth onboarding of a new CEO to lead the Company forward in its next phase of growth.' Article content Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor of cannabis and manufacturer of cannabis-derived goods in Canada. Through its recent acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets. Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, Collective Project, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Article content This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as 'plans', 'expects', 'estimates', 'intends', 'anticipates', 'believes' or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include consumer demand and preferences, future prospects and factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see and filed or furnished to the Securities and Exchange Commission on EDGAR (see Article content Examples of forward-looking statements in this news release include, among others, statements regarding the Board's intended CEO selection process, Organigram's strategic direction and Ms. Goldenberg's planned focus until her retirement date. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Article content Article content Article content Article content Article content Article content
National Post
07-05-2025
- Business
- National Post
Organigram Global's Collective Project Wins Big at the 2025 High Spirits Awards in California
Article content TORONTO — Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the 'Company' or 'Organigram'), Canada's #1 cannabis company by market share, is pleased to announce that its recently acquired business, Collective Project, has won recognition at the 2025 High Spirits Awards only a few short months following the launch of the brand in the U.S. The brand received a gold award for Blood Orange, Yuzu & Vanilla and a platinum award for Mango, Pineapple & Coconut hemp-derived THC beverages. High Spirits Awards is a competition launched by L.A. Spirits Awards in 2023 to identify and reward excellence among the growing number of cannabis- and hemp-derived beverages available to consumers. Article content Blood Orange, Yuzu & Vanilla is a fan-favourite beverage that is rapidly earning recognition in the U.S. following its recent launch. It has big citrusy notes of yuzu and blood orange, blended with vanilla and infused with THC. Mango, Pineapple and Coconut is a classic tropical blend with Piña Colada flavours infused with THC. Both beverages are packed with real fruit juice and inspired by the global art community. Article content 'Seeing Collective Project products celebrated in the U.S. is a proud moment for us,' said Beena Goldenberg, CEO of Organigram. 'This early momentum, so soon after our acquisition, reinforces the brand's strong consumer connection and innovative edge. It also validates our strategy to accelerate growth in the U.S. cannabis beverage space—where demand for elevated, experience-driven products is clearly gaining ground.' Article content The Collective Project portfolio is currently available across several U.S. states, including Minnesota, Florida, Texas, South Carolina, North Carolina, Georgia, Ohio, Tennessee, and Alabama, and can be found at major retail chains such as Top Ten Liquors and Total Wine & More. An eCommerce website is set to launch in the coming weeks supporting the brand's continued expansion and growing product lineup. Article content About Organigram Article content Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada, and Motif Labs Ltd., a licensed cannabis processor. Through its recent acquisition of Collective Project Limited, Organigram Global participates in the U.S. and Canadian cannabinoid beverages markets. Article content Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, Collective Project, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Article content This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as 'plans', 'expects', 'estimates', 'intends', 'anticipates', 'believes' or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include consumer demand and preferences and factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see and filed or furnished to the Securities and Exchange Commission on EDGAR (see Examples of forward-looking statements in this news release include, among others, the opportunities for cannabis beverages in the U.S. and Organigram's ability to establish a U.S. market position over time for hemp-derived THC products in beverages. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release is made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. Article content Article content Article content Article content Contacts Article content For Media enquiries: Article content Article content Article content
Yahoo
07-04-2025
- Business
- Yahoo
Organigram snaps up cannabis-drinks business Collective Project
Organigram, the Canadian cannabis group, has struck a deal in the cannabis-drinks market with a move for Collective Project. Nasdaq-listed Organigram said it would pay an initial C$6.2m (US$4.4m) for Collective Project, a business based in Ontario but which sells in Canada and the US. 'In an environment where consumers are shifting away from alcohol, brands that deliver on an enjoyable experience without the negative effects of alcohol will be poised to win in this alternative beverage category that is growing at a rapid rate in the US,' Organigram chief strategy officer Paolo De Luca said. Collective Project, based in Hamilton, produces cannabis and hemp-derived infused sparkling juices, teas and sodas. The company markets its drinks in Canada and in ten US states. Its US stockists include Top Ten Liquors in Minnesota and Total Wines in the states of North Carolina, South Carolina and Indiana. Organigram is buying the Collective Project business from Collective Arts, which will retain its alcohol assets. Collective Arts sells beer in both markets. De Luca added: 'We believe that Collective Project's portfolio of cannabis and hemp-derived THC beverages are differentiated, among the best-tasting products in the market today, and are sure to please consumers looking for a satisfying beverage alternative in both the US and Canada.' Under the terms of the deal, Organigram said it could pay a total of C$24m once 'potential milestone payments and potential earnout payments' are included. Organigram said it expects Collective Project's drinks will be available in four more US states by the end of the year. 'The acquisition of Collective Project marks yet another strategic milestone towards Organigram's global leadership ambitions. Not only does this acquisition represent our first commercial entry into the fast-growing hemp-derived THC beverage market in the US, it also fast-tracks our entry into the cannabis beverage category in Canada, a category that we believe is on the cusp of growth at home as well,' Organigram CEO Beena Goldenberg added. "Organigram snaps up cannabis-drinks business Collective Project" was originally created and published by Just Drinks, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
